WO2005018552A3 - Heparin binding proteins: sensors for heparin detection - Google Patents

Heparin binding proteins: sensors for heparin detection Download PDF

Info

Publication number
WO2005018552A3
WO2005018552A3 PCT/US2004/026066 US2004026066W WO2005018552A3 WO 2005018552 A3 WO2005018552 A3 WO 2005018552A3 US 2004026066 W US2004026066 W US 2004026066W WO 2005018552 A3 WO2005018552 A3 WO 2005018552A3
Authority
WO
WIPO (PCT)
Prior art keywords
heparin
sensors
binding proteins
detection
heparin binding
Prior art date
Application number
PCT/US2004/026066
Other languages
French (fr)
Other versions
WO2005018552A2 (en
Inventor
Glenn D Prestwich
Cal Shenshen
Jodi Beattie
Michael J Mostert
Original Assignee
Univ Utah Res Found
Glenn D Prestwich
Cal Shenshen
Jodi Beattie
Michael J Mostert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Glenn D Prestwich, Cal Shenshen, Jodi Beattie, Michael J Mostert filed Critical Univ Utah Res Found
Priority to JP2006523341A priority Critical patent/JP2007502112A/en
Priority to EP04780840A priority patent/EP1668359A2/en
Priority to AU2004266642A priority patent/AU2004266642A1/en
Priority to CA002536504A priority patent/CA2536504A1/en
Publication of WO2005018552A2 publication Critical patent/WO2005018552A2/en
Publication of WO2005018552A3 publication Critical patent/WO2005018552A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

This invention, in one aspect, relates to a composition comprising a heparin binding protein and nucleic acids thereof, as well as methods for making the protein and the nucleic acid, and methods of using the heparin binding protein and nucleic acid thereof.
PCT/US2004/026066 2003-08-12 2004-08-12 Heparin binding proteins: sensors for heparin detection WO2005018552A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006523341A JP2007502112A (en) 2003-08-12 2004-08-12 Heparin-binding protein: a sensor for heparin detection
EP04780840A EP1668359A2 (en) 2003-08-12 2004-08-12 Heparin binding proteins: sensors for heparin detection
AU2004266642A AU2004266642A1 (en) 2003-08-12 2004-08-12 Heparin binding proteins: sensors for heparin detection
CA002536504A CA2536504A1 (en) 2003-08-12 2004-08-12 Heparin binding proteins: sensors for heparin detection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49449503P 2003-08-12 2003-08-12
US60/494,495 2003-08-12

Publications (2)

Publication Number Publication Date
WO2005018552A2 WO2005018552A2 (en) 2005-03-03
WO2005018552A3 true WO2005018552A3 (en) 2005-07-28

Family

ID=34215876

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/026066 WO2005018552A2 (en) 2003-08-12 2004-08-12 Heparin binding proteins: sensors for heparin detection

Country Status (5)

Country Link
EP (1) EP1668359A2 (en)
JP (1) JP2007502112A (en)
AU (1) AU2004266642A1 (en)
CA (1) CA2536504A1 (en)
WO (1) WO2005018552A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8986713B2 (en) 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8496953B2 (en) 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8865412B2 (en) 2008-05-28 2014-10-21 Baxter International Inc. Methods and assays for oversulfated glycosaminoglycans
SG174217A1 (en) * 2009-03-02 2011-10-28 Japan Tobacco Inc Method for detecting substance in biological sample
US8591932B2 (en) 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
RU2625756C2 (en) 2011-03-11 2017-07-18 В.Л. Гор Энд Ассошиейтс, Инк. Advanced immobilized biological objects
RU2015123315A (en) 2012-11-25 2017-01-10 Зе Реджентс Оф Зе Юниверсити Оф Калифорния Peptides that stimulate subcutaneous adipogenesis
US10844102B2 (en) 2014-05-28 2020-11-24 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
CN113945718A (en) * 2020-03-04 2022-01-18 上海奥普生物医药股份有限公司 Heparin binding protein detection kit, preparation method and application
CN114062685B (en) * 2021-11-24 2023-12-26 武汉尚恩生物技术有限公司 Kit for identifying cell species based on ELISA double-antibody sandwich method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
US5306619A (en) * 1991-06-27 1994-04-26 Genelabs Technologies, Inc. Screening assay for the detection of DNA-binding molecules
US5792850A (en) * 1996-05-23 1998-08-11 Zymogenetics, Inc. Hematopoietic cytokine receptor
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US6200955B1 (en) * 1996-06-11 2001-03-13 Commonwealth Biotechnologies, Inc. Heparin binding peptides

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
US5306619A (en) * 1991-06-27 1994-04-26 Genelabs Technologies, Inc. Screening assay for the detection of DNA-binding molecules
US5792850A (en) * 1996-05-23 1998-08-11 Zymogenetics, Inc. Hematopoietic cytokine receptor
US6200955B1 (en) * 1996-06-11 2001-03-13 Commonwealth Biotechnologies, Inc. Heparin binding peptides
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent

Also Published As

Publication number Publication date
EP1668359A2 (en) 2006-06-14
CA2536504A1 (en) 2005-03-03
JP2007502112A (en) 2007-02-08
AU2004266642A1 (en) 2005-03-03
WO2005018552A2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
WO2008028977A3 (en) Serum albumin binding proteins with long half-lives
WO2006031800A3 (en) Reverse transfection of cell arrays
WO2005047511A3 (en) Bacterial expression of protease inhibitors and variants thereof
WO2005042695A3 (en) Lipoparticles comprising proteins, methods of making, and using the same
WO2005014850A3 (en) Systems and methods for analyzing nucleic acid sequences
IL169804A (en) 254p1d6b proteins, nucleic acids encoding the same, processes for producing the same, antibodies binding thereto and uses thereof
WO2005017205A3 (en) Nucleic acid mapping using linear analysis
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2005018552A3 (en) Heparin binding proteins: sensors for heparin detection
WO2002024912A3 (en) Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
WO2006047728A3 (en) Bmp gene and fusion protein
WO2006056438A3 (en) Protein-biochip for validating binding agents
WO2006073971A3 (en) Binding protein with a scaffold for varying specificity
WO2005086654A3 (en) Self-cleaving affinity tags and methods of use
WO2006079334A3 (en) Protein identifying and quantifying method
WO2005000862A3 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
WO2001066752A3 (en) Reproduction-specific genes
WO2003093434A3 (en) Nanoarchaeum nucleic acid molecule
WO2006097336A3 (en) A novel component of the wg/wnt signaling pathway
WO2006013462A3 (en) Growth factors nsg28, nsg30, and nsg32
PL379564A1 (en) Btl-ii nucleic acids, proteins, and antibodies
AU2003270130A1 (en) Acid soluble proteins from micellar casein
WO2000077208A3 (en) Gustatory receptors in drosophila
WO2001048227A8 (en) Method for production of proteins in host cells involving the use of chaperonins
WO2005052193A3 (en) Methods for determining the degradation state or concentration of nucleic acids

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2536504

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006523341

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004266642

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004780840

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004266642

Country of ref document: AU

Date of ref document: 20040812

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004266642

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200480029928.7

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2004780840

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004780840

Country of ref document: EP